aTYR PHARMA (ATYR) Current Deferred Revenue (2014 - 2020)
aTYR PHARMA's (ATYR) quarterly Current Deferred Revenue came in at $53000.0 in Q3 2020, down 84.94% YoY from $352000.0 in Q4 2019, and down 73.63% on a QoQ basis from $201000.0 in Q2 2020.
aTYR PHARMA (ATYR) Current Deferred Revenue (2014 - 2020) Analysis & Trends
aTYR PHARMA (ATYR) has 6 years of Current Deferred Revenue data on file, last reported at $53000.0 in Q3 2020.
- Quarterly Current Deferred Revenue fell 84.94% year-over-year to $53000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $53000.0 (down 84.94% YoY) and the FY2019 annual result came in at $208000.0, changed N/A from the prior year.
- Current Deferred Revenue retreated to $53000.0 in Q3 2020, from $201000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $630000.0 in Q1 2019 to a low of $49000.0 in Q1 2017.
- A 4-year average of $260333.3 and a median of $209500.0 in 2016 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2016 — Current Deferred Revenue climbed 6.67% — and 2020, when it sank 84.94%.
- Tracing ATYR's Current Deferred Revenue over 4 years: stood at $130000.0 in 2016, then tumbled by 62.31% to $49000.0 in 2017, then jumped by 324.49% to $208000.0 in 2019, then sank by 74.52% to $53000.0 in 2020.
- The last three Current Deferred Revenue figures came in at $53000.0 (Q3 2020), $201000.0 (Q2 2020), and $143000.0 (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | aTYR PHARMA | 49.54 Mn | -7.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 53,000.00 |
| Jun 30, 2020 | 201,000.00 |
| Mar 31, 2020 | 143,000.00 |
| Dec 31, 2019 | 208,000.00 |
| Sep 30, 2019 | 352,000.00 |
| Jun 30, 2019 | 536,000.00 |
| Mar 31, 2019 | 630,000.00 |
| Mar 31, 2017 | 49,000.00 |
| Dec 31, 2016 | 130,000.00 |
| Sep 30, 2016 | 211,000.00 |
| Jun 30, 2016 | 291,000.00 |
| Mar 31, 2016 | 320,000.00 |
| Dec 31, 2015 | 315,000.00 |
| Sep 30, 2015 | 310,000.00 |
| Jun 30, 2015 | 305,000.00 |
| Mar 31, 2015 | 300,000.00 |
| Dec 31, 2014 | 295,000.00 |